Trial Profile
A Phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2011
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck & Co
- 09 Mar 2011 New trial record